In summary, we have demonstrated a novel anti-proliferative effect of M1R activation in human colon cancer cells that may explain why CHRM1/M1R levels in colon cancer are relatively reduced compared to CHRM3/M3R levels. Here, CHRM1 is linked to malignant colon neoplasm.